Testing Reinforcer Pathology: Mechanisms and Interventions to Change Alcohol Valuation
Testing Reinforcer Pathology: Mechanisms and Interventions to Change Alcohol Valuation
批准号:
10679071
负责人:
Warren K Bickel
金额:
$65.59万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-08-31
关键词:
AddressAgeAlcohol consumptionAlcoholsAmygdaloid structureAnteriorBehavioralBiological ModelsBrain regionClinicalComputer ModelsDataEconomicsEnvironmentEvidence based treatmentFunctional Magnetic Resonance ImagingFutureGenerationsGoalsHippocampusIndividualIndividual DifferencesInterventionLaboratoriesLaboratory SensitivityLateralLearningLengthLinkLiteratureMeasuresMedicineMethodsModelingNatureNeurobiologyNeurocognitiveOutcomeOutpatientsParticipantPathologyPharmaceutical PreparationsPharmacological TreatmentPrefrontal CortexProcessPsychological reinforcementPublic HealthResearchResearch Project GrantsSelf AdministrationSpecific qualifier valueTestingThinkingTimeTranslational ResearchVentral StriatumWorkaddictionalcohol abuse therapyalcohol demandalcohol interventionalcohol related problemalcohol use disorderbehavioral economicsbiobehaviorcognitive controlcomparison controlcomputational neurosciencecravingdiscountingefficacious interventionexperimental studyfield studyimprovedinnovationinsightinterestintervention effectmathematical modelneuralneurofeedbackneuroimagingnovelopen innovationpsychosocialreinforcerremote monitoringsexsimulationtheoriestherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Developing a new generation of interventions for alcohol use disorder (AUD) constitutes an important scientific
gap and, if addressed, will open innovation opportunities. To address this gap, we propose to examine an
emerging novel framework for addiction, reinforcer pathology. Reinforcer pathology specifies that reinforcers are
integrated over a temporal window, and the length of that window determines the relative value of different
reinforcers. When the temporal window is short, reinforcers such as alcohol, which are brief, intense, and reliable,
will have greater value. Conversely, as the temporal window lengthens, other more temporally extended
reinforcers begin to have greater influence and alcohol valuation will decrease. The concept of reinforcer
pathology identifies the temporal window, measured with delay discounting (i.e., the decline in the value of a
reinforcer as a function of its delay), as a therapeutic target for AUD, and it permits target engagement via
innovative interventions (e.g., episodic future thinking; EFT) to provide novel insights into alcohol valuation. This
project uses multiple analytical levels (e.g., the behavioral laboratory, an outpatient field study, neuroimaging,
and computational modeling) to quantify, predict, and modulate alcohol valuation among individuals with AUD.
In Aim 1, we will examine manipulations that increase and decrease the temporal window to mechanistically test
the reinforcer pathology framework. In Aim 1a, we will examine the effects of an intervention that increases the
temporal window (EFT) on concomitant changes in alcohol valuation (self-administration, craving, and behavioral
economic alcohol demand). In addition, participants in Aim 1a will participate in a proof-of-concept field study,
where remote implementation of EFT will be used to impact alcohol drinking (measured by remote monitoring of
breath alcohol) in the natural environment. In Aim1b, we will examine the effects of a manipulation that decreases
the temporal window (simulation of economic scarcity) on concomitant changes in alcohol valuation. Throughout
Aim 1, neural activity associated with changes in the temporal window will also be examined. In Aim 2, we will
use multi-voxel analyses of fMRI data to explore two independent sub-aims related to reinforcer pathology in
AUD. First, in Aim 2a, we will build multivariate group regression models of fMRI delay discounting data in a
subset of participants with AUD to predict discounting in an independent subset of participants. Second, in Aim
2b, we will use real-time fMRI neurofeedback to enhance participants' ability to control their temporal window,
and hence their ability to modulate delay discounting and alcohol valuation. In Aim 3, we will model the temporal
window to extend the existing literature by computationally quantifying results from Aims 1 and 2 (Aim 3a), and
connecting subjective value to brain regions of interest using computational neuroscience (Aim 3b). Together,
the findings from this rigorous and innovative research project will improve our understanding of AUD and
highlight potential novel and efficacious intervention strategies.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1037/pha0000389
发表时间:
2022-02
期刊:
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
影响因子:
2.3
作者:
[Athamneh, Liqa N., Lemos, Roberta Freitas, Basso, Julia C., Tomlinson, Devin C., Craft, William H., Stein, Madison D., Bickel, Warren K.]
通讯作者:
Bickel, Warren K.
DOI:
10.1111/acer.15020
发表时间:
2023-02
期刊:
Alcoholism, clinical and experimental research
影响因子:
--
作者:
[W. H. Craft;Candice L. Dwyer;D. Tomlinson;Yu-Hua Yeh;A. Tegge;Warren K. Bickel]
通讯作者:
W. H. Craft;Candice L. Dwyer;D. Tomlinson;Yu-Hua Yeh;A. Tegge;Warren K. Bickel
DOI:
10.1037/pha0000549
发表时间:
2022-08
期刊:
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
影响因子:
2.3
作者:
[Craft, William H., Tegge, Allison N., Freitas-Lemos, Roberta, Tomlinson, Devin C., Bickel, Warren K.]
通讯作者:
Bickel, Warren K.
DOI:
10.1016/j.jsat.2021.108665
发表时间:
2022-05
期刊:
Journal of substance abuse treatment
影响因子:
3.9
作者:
[Craft WH, Tegge AN, Athamneh LN, Tomlinson DC, Freitas-Lemos R, Bickel WK]
通讯作者:
Bickel WK
DOI:
10.1016/j.drugalcdep.2021.108795
发表时间:
2021-08-01
期刊:
Drug and alcohol dependence
影响因子:
4.2
作者:
[Snider SE, Turner JK, McClure SM, Bickel WK]
通讯作者:
Bickel WK
共 8 条
Longitudinal Study of Recovery: Psychosocial Functioning, Relapse, and Neuro-Behavioral Markers
-
批准号:10577761
-
项目类别:
-
资助金额:$70.96万
-
财政年份:2022
-
负责人:Warren K Bickel
-
依托单位:
An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology
-
批准号:10454007
-
项目类别:
-
资助金额:$71.88万
-
财政年份:2022
-
负责人:Warren K Bickel
-
依托单位:
Longitudinal Study of Recovery: Psychosocial Functioning, Relapse, and Neuro-Behavioral Markers
-
批准号:10367669
-
项目类别:
-
资助金额:$72.52万
-
财政年份:2022
-
负责人:Warren K Bickel
-
依托单位:
Experimental Tobacco Marketplace: Forecasting the Health Equity of Novel Tax Proposals
-
批准号:10522270
-
项目类别:
-
资助金额:$69.49万
-
财政年份:2022
-
负责人:Warren K Bickel
-
依托单位:
Experimental Tobacco Marketplace: Forecasting the Health Equity of Novel Tax Proposals
-
批准号:10661063
-
项目类别:
-
资助金额:$66.07万
-
财政年份:2022
-
负责人:Warren K Bickel
-
依托单位:
An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology
-
批准号:10661032
-
项目类别:
-
资助金额:$70.95万
-
财政年份:2022
-
负责人:Warren K Bickel
-
依托单位:
Testing Reinforcer Pathology: Mechanisms and Interventions to Change Alcohol Valuation
-
批准号:10001412
-
项目类别:
-
资助金额:$70.95万
-
财政年份:2019
-
负责人:Warren K Bickel
-
依托单位:
Translational approaches to TMS treatment development for smoking
-
批准号:10053029
-
项目类别:
-
资助金额:$52.66万
-
财政年份:2019
-
负责人:Warren K Bickel
-
依托单位:
Testing Reinforcer Pathology: Mechanisms and Interventions to Change Alcohol Valuation
-
批准号:10259857
-
项目类别:
-
资助金额:$68.49万
-
财政年份:2019
-
负责人:Warren K Bickel
-
依托单位:
Project 3: The abuse liability and substitution profile of removing cigarette ventilation in the experimental tobacco marketplace
-
批准号:10246920
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2017
-
负责人:Warren K Bickel
-
依托单位:
The Experimental Tobacco Marketplace (ETM)
-
批准号:10270165
-
项目类别:
-
资助金额:$14.08万
-
财政年份:2016
-
负责人:Warren K Bickel
-
依托单位:
Abuse liability of reduced nicotine content cigarettes within a complex tobacco marketplace
-
批准号:9194519
-
项目类别:
-
资助金额:$52.86万
-
财政年份:2016
-
负责人:Warren K Bickel
-
依托单位:
The Experimental Tobacco Marketplace (ETM)
-
批准号:10693260
-
项目类别:
-
资助金额:$14.39万
-
财政年份:2016
-
负责人:Warren K Bickel
-
依托单位:
The Experimental Tobacco Marketplace (ETM)
-
批准号:10493304
-
项目类别:
-
资助金额:$16.09万
-
财政年份:2016
-
负责人:Warren K Bickel
-
依托单位:
Delay discounting as a target for self-regulation in prediabetes
-
批准号:9134756
-
项目类别:
-
资助金额:$71.06万
-
财政年份:2015
-
负责人:Warren K Bickel
-
依托单位:
Delay discounting as a target for self-regulation in prediabetes
-
批准号:9300915
-
项目类别:
-
资助金额:$76.45万
-
财政年份:2015
-
负责人:Warren K Bickel
-
依托单位:
Delay discounting as a target for self-regulation in prediabetes
-
批准号:9038709
-
项目类别:
-
资助金额:$89.21万
-
财政年份:2015
-
负责人:Warren K Bickel
-
依托单位:
Delay discounting as a target for self-regulation in prediabetes
-
批准号:9235553
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2015
-
负责人:Warren K Bickel
-
依托单位:
The Social Interactome of Recovery: Social Media as Therapy Development
-
批准号:8827477
-
项目类别:
-
资助金额:$56.47万
-
财政年份:2014
-
负责人:Warren K Bickel
-
依托单位:
The Social Interactome of Recovery: Social Media as Therapy Development
-
批准号:9132198
-
项目类别:
-
资助金额:$54.61万
-
财政年份:2014
-
负责人:Warren K Bickel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: